Factor V Leiden: is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?

[1]  B. Dahlbäck,et al.  Activated protein C resistance – in the absence of factor V Leiden – and pregnancy , 2006, Journal of thrombosis and haemostasis : JTH.

[2]  D. Lacombe,et al.  Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics. , 2005, Molecular genetics and metabolism.

[3]  M. Cushman.  Inherited risk factors for venous thrombosis. , 2005, Hematology. American Society of Hematology. Education Program.

[4]  A. Biswas,et al.  Protein C system defects in Indian children with thrombosis , 2005, Annals of Hematology.

[5]  R. Bertina,et al.  Factor Va Is Inactivated by Activated Protein C in the Absence of Cleavage Sites at Arg-306, Arg-506, and Arg-679* , 2004, Journal of Biological Chemistry.

[6]  Pawan Gupta,et al.  Factor V Leiden--the commonest molecular defect in arterial and venous thrombophilia in India. , 2003, Thrombosis research.

[7]  R. Marlar,et al.  Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden. , 2003, American journal of clinical pathology.

[8]  M. Laposata,et al.  Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm. , 2002, Archives of pathology & laboratory medicine.

[9]  T. Orfeo,et al.  Homocysteine Inhibits Inactivation of Factor Va by Activated Protein C* , 2001, The Journal of Biological Chemistry.

[10]  D. Girelli,et al.  Mutations in the R2 FV Gene Affect the Ratio between the Two FV Isoforms in Plasma , 2000, Thrombosis and Haemostasis.

[11]  N. Tatsumi,et al.  A Thai Patient with the Mutation of Arg306 of FV Gene Identical to the Hong Kong but not to the Cambridge Type , 1999, Thrombosis and Haemostasis.

[12]  R. Kaufman,et al.  Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V. , 1999, Blood.

[13]  R. Liang,et al.  A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. , 1998, Blood.

[14]  T. Baglin,et al.  Factor V Cambridge: a new mutation (Arg306-->Thr) associated with resistance to activated protein C. , 1998, Blood.

[15]  E. Sacchi,et al.  A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype , 1997 .

[16]  B. Giusti,et al.  Prevalence of Factor V Leiden Mutation in Non-European Populations , 1997, Thrombosis and Haemostasis.

[17]  J. Rosing,et al.  Factor V Enhances the Cofactor Function of Protein S in the APC-Mediated Inactivation of Factor VIII: Influence of the Factor VR506Q Mutation , 1996, Thrombosis and Haemostasis.

[18]  L. Iacoviello,et al.  Detection of New Polymorphic Markers in the Factor V Gene: Association with Factor V Levels in Plasma , 1996, Thrombosis and Haemostasis.

[19]  H. Hemker,et al.  Peptide Bond Cleavages and Loss of Functional Activity during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C (*) , 1995, The Journal of Biological Chemistry.

[20]  P. Reitsma,et al.  High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) , 1995, Blood.

[21]  K. Mann,et al.  Characterization of the Molecular Defect in Factor VR506A(*) , 1995, The Journal of Biological Chemistry.